Yamasa Corporation

About Yamasa Corporation

Yamasa Biochemicals Division has advanced research for the next generation in nucleic acid related compounds which are now used in broad fields such as APIs, and pharmaceutical intermediates. Along with our abundant experience and technology accumulated for many years, Yamasa provides products and contract services which realize your various needs. 

  • JP
  • 2015
    On CPHI since
Contact info
Meet us at

CPHI Japan 2024

East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
17 Apr 2024 – 19 Apr 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Yamasa Corporation (5)

  • Oligonucleotides

    Product Oligonucleotides

    Yamasa corporation offers a wide range of biochemicals products which includes oligonucleotides. Contact us for more information.
  • Amidite monomers

    Product Amidite monomers

    Yamasa corporation offers a wide range of biochemicals products which includes amidite monomers. Contact us for more information.
  • Adenosine (Adenosine)

    Product Adenosine (Adenosine)

    Yamasa corporation offers a wide range of biochemicals products which includes adenosine (adenosine). Contact us for more information.
  • Adenosine 5'-monophosphate, disodium salt (5'-AMP, 2Na)

    Product Adenosine 5'-monophosphate, disodium salt (5'-AMP, 2Na)

    Yamasa corporation offers a wide range of biochemicals products which includes adenosine 5'-monophosphate, disodium salt (5'-amp, 2na). Contact us for more information.
  • Adenosine 5'-monophosphate, free acid (5'-AMP, free)

    Product Adenosine 5'-monophosphate, free acid (5'-AMP, free)

    Yamasa corporation offers a wide range of biochemicals products which includes adenosine 5'-monophosphate, free acid (5'-amp, free). Contact us for more information.

Yamasa Corporation Resources (1)

  • News Assist in Drug Development of Oligonucleotides

    Utilizing our experience of synthesizing various nucleic acid related compounds over 60 years, Yamasa can collaborate in development of new monomers used in drug development of oligonucleotides.